Concepedia
Statistics
Publications
22
Citations
1.6K
H-Index
19
Active since
2009
Affiliations
Emory University(Current)
Winship Cancer Institute
United States Department of Veterans Affairs
Johns Hopkins University
University of Maryland, Baltimore
Michael Y. Bonner is an author at Emory University specializing in medicine, oncology, and pharmacology.
Publications per year
2009–2021
Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3
Vinodkumar B. Pillai, Sadhana Samant, Nagalingam R. Sundaresan et al. · Nature Communications · 2015 · 435 citations · Full text
Life Sciences, Biochemistry, Pharmacology +17
Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice
Sulochana S. Bhandarkar, Marisa Jaconi, Levi Fried et al. · Journal of Clinical Investigation · 2009 · 112 citations · Full text
Medicine, Oncology, Pharmacology +14
Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma
Jennifer M. Munson, Levi Fried, Sydney A. Rowson et al. · Science Translational Medicine · 2012 · 111 citations
Medicine, Oncology, Pharmacology +16
SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis
Kaname Akamata, Jun Wei, Mitra Bhattacharyya et al. · Oncotarget · 2016 · 109 citations · Full text
Medicine, Dermatology, Pathology +17
Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis
Arumugam Nagalingam, Jack L. Arbiser, Michael Y. Bonner et al. · Breast Cancer Research · 2012 · 101 citations · Full text
Medicine, Oncology, Pharmacology +13
1–5 of 22